Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs

Detalhes bibliográficos
Autor(a) principal: Barbosa, C. F. [UNESP]
Data de Publicação: 2007
Outros Autores: Okuda, E. S. [UNESP], Chung, M. C. [UNESP], Ferreira, E. I., Cicarelli, R. M.B. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1590/S0100-879X2007000100005
http://hdl.handle.net/11449/224854
Resumo: No fully effective treatment has been developed since the discovery of Chagas' disease by Carlos Chagas in 1909. Since drug-resistant Trypanosoma cruzi strains are occurring and the current therapy is effectiveness in the acute phase but with various adverse side effects, more studies are needed to characterize the susceptibility of T. cruzi to new drugs. Many natural and/or synthetic substances showing trypanocidal activity have been used, even though they are not likely to be turned into clinically approved drugs. Originally, drug screening was performed using natural products, with only limited knowledge of the molecular mechanism involved in the development of diseases. Trans-splicing, which is unusual RNA processing reaction and occurs in nematodes and trypanosomes, implies the processing of polycistronic transcription units into individual mRNAs; a short transcript spliced leader (SL RNA) is trans-spliced to the acceptor pre-mRNA, giving origin to the mature mRNA. In the present study, permeable cells of T. cruzi epimastigote forms (Y, BOL and NCS strains) were treated to evaluate the interference of two drugs (hydroxymethylnitrofurazone- NFOH-121 and nitrofurazone) in the trans-splicing reaction using silver-stained PAGE analysis. Both drugs induced a significant reduction in RNA processing at concentrations from 5 to 12.5 μM. These data agreed with the biological findings, since the number of parasites decreased, especially with NFOH-121, This proposed methodology allows a rapid and cost-effective screening strategy for detecting drug interference in the trans-splicing mechanis of T. cruzi. © 2007 Brazilian Journal of Medical and Biological Research.
id UNSP_cd712bccfbc17b03ff1fd6a664cf1975
oai_identifier_str oai:repositorio.unesp.br:11449/224854
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAsHydroxymethylnitrofurazonePermeable cellsRNA processingTrans-splicingTrypanocidal drugsTrypanosoma cruziNo fully effective treatment has been developed since the discovery of Chagas' disease by Carlos Chagas in 1909. Since drug-resistant Trypanosoma cruzi strains are occurring and the current therapy is effectiveness in the acute phase but with various adverse side effects, more studies are needed to characterize the susceptibility of T. cruzi to new drugs. Many natural and/or synthetic substances showing trypanocidal activity have been used, even though they are not likely to be turned into clinically approved drugs. Originally, drug screening was performed using natural products, with only limited knowledge of the molecular mechanism involved in the development of diseases. Trans-splicing, which is unusual RNA processing reaction and occurs in nematodes and trypanosomes, implies the processing of polycistronic transcription units into individual mRNAs; a short transcript spliced leader (SL RNA) is trans-spliced to the acceptor pre-mRNA, giving origin to the mature mRNA. In the present study, permeable cells of T. cruzi epimastigote forms (Y, BOL and NCS strains) were treated to evaluate the interference of two drugs (hydroxymethylnitrofurazone- NFOH-121 and nitrofurazone) in the trans-splicing reaction using silver-stained PAGE analysis. Both drugs induced a significant reduction in RNA processing at concentrations from 5 to 12.5 μM. These data agreed with the biological findings, since the number of parasites decreased, especially with NFOH-121, This proposed methodology allows a rapid and cost-effective screening strategy for detecting drug interference in the trans-splicing mechanis of T. cruzi. © 2007 Brazilian Journal of Medical and Biological Research.Departamento de Ciências Biológicas Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, Rod. Araraquara-Jaú, km 01, 14801-902 Araraquara, SPDepartamento de Fármacos e Medicamentos Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, Rod. Araraquara-Jaú, km 01, 14801-902 Araraquara, SPDepartamento de Farmácia Faculdade de Ciências Farmacêuticas Universidade de São Paulo, São Paulo, SPDepartamento de Ciências Biológicas Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, Rod. Araraquara-Jaú, km 01, 14801-902 Araraquara, SPDepartamento de Fármacos e Medicamentos Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, Rod. Araraquara-Jaú, km 01, 14801-902 Araraquara, SPUniversidade Estadual Paulista (UNESP)Universidade de São Paulo (USP)Barbosa, C. F. [UNESP]Okuda, E. S. [UNESP]Chung, M. C. [UNESP]Ferreira, E. I.Cicarelli, R. M.B. [UNESP]2022-04-28T20:14:43Z2022-04-28T20:14:43Z2007-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article33-39http://dx.doi.org/10.1590/S0100-879X2007000100005Brazilian Journal of Medical and Biological Research, v. 40, n. 1, p. 33-39, 2007.0100-879X1678-4510http://hdl.handle.net/11449/22485410.1590/S0100-879X20070001000052-s2.0-33846271829Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBrazilian Journal of Medical and Biological Researchinfo:eu-repo/semantics/openAccess2024-06-24T13:45:50Zoai:repositorio.unesp.br:11449/224854Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T18:55:41.585321Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
title Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
spellingShingle Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
Barbosa, C. F. [UNESP]
Hydroxymethylnitrofurazone
Permeable cells
RNA processing
Trans-splicing
Trypanocidal drugs
Trypanosoma cruzi
title_short Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
title_full Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
title_fullStr Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
title_full_unstemmed Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
title_sort Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
author Barbosa, C. F. [UNESP]
author_facet Barbosa, C. F. [UNESP]
Okuda, E. S. [UNESP]
Chung, M. C. [UNESP]
Ferreira, E. I.
Cicarelli, R. M.B. [UNESP]
author_role author
author2 Okuda, E. S. [UNESP]
Chung, M. C. [UNESP]
Ferreira, E. I.
Cicarelli, R. M.B. [UNESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Barbosa, C. F. [UNESP]
Okuda, E. S. [UNESP]
Chung, M. C. [UNESP]
Ferreira, E. I.
Cicarelli, R. M.B. [UNESP]
dc.subject.por.fl_str_mv Hydroxymethylnitrofurazone
Permeable cells
RNA processing
Trans-splicing
Trypanocidal drugs
Trypanosoma cruzi
topic Hydroxymethylnitrofurazone
Permeable cells
RNA processing
Trans-splicing
Trypanocidal drugs
Trypanosoma cruzi
description No fully effective treatment has been developed since the discovery of Chagas' disease by Carlos Chagas in 1909. Since drug-resistant Trypanosoma cruzi strains are occurring and the current therapy is effectiveness in the acute phase but with various adverse side effects, more studies are needed to characterize the susceptibility of T. cruzi to new drugs. Many natural and/or synthetic substances showing trypanocidal activity have been used, even though they are not likely to be turned into clinically approved drugs. Originally, drug screening was performed using natural products, with only limited knowledge of the molecular mechanism involved in the development of diseases. Trans-splicing, which is unusual RNA processing reaction and occurs in nematodes and trypanosomes, implies the processing of polycistronic transcription units into individual mRNAs; a short transcript spliced leader (SL RNA) is trans-spliced to the acceptor pre-mRNA, giving origin to the mature mRNA. In the present study, permeable cells of T. cruzi epimastigote forms (Y, BOL and NCS strains) were treated to evaluate the interference of two drugs (hydroxymethylnitrofurazone- NFOH-121 and nitrofurazone) in the trans-splicing reaction using silver-stained PAGE analysis. Both drugs induced a significant reduction in RNA processing at concentrations from 5 to 12.5 μM. These data agreed with the biological findings, since the number of parasites decreased, especially with NFOH-121, This proposed methodology allows a rapid and cost-effective screening strategy for detecting drug interference in the trans-splicing mechanis of T. cruzi. © 2007 Brazilian Journal of Medical and Biological Research.
publishDate 2007
dc.date.none.fl_str_mv 2007-01-01
2022-04-28T20:14:43Z
2022-04-28T20:14:43Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0100-879X2007000100005
Brazilian Journal of Medical and Biological Research, v. 40, n. 1, p. 33-39, 2007.
0100-879X
1678-4510
http://hdl.handle.net/11449/224854
10.1590/S0100-879X2007000100005
2-s2.0-33846271829
url http://dx.doi.org/10.1590/S0100-879X2007000100005
http://hdl.handle.net/11449/224854
identifier_str_mv Brazilian Journal of Medical and Biological Research, v. 40, n. 1, p. 33-39, 2007.
0100-879X
1678-4510
10.1590/S0100-879X2007000100005
2-s2.0-33846271829
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Brazilian Journal of Medical and Biological Research
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 33-39
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808129000082505728